- Home
- ILAG vs LYRA Comparison
ILAG vs LYRA Comparison
Compare ILAG & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- LYRA
- Stock Information
- Founded
- ILAG 1981
- LYRA 2005
- Country
- ILAG Hong Kong
- LYRA United States
- Employees
- ILAG N/A
- LYRA N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- LYRA Medical/Dental Instruments
- Sector
- ILAG Consumer Discretionary
- LYRA Health Care
- Exchange
- ILAG Nasdaq
- LYRA Nasdaq
- Market Cap
- ILAG 12.1M
- LYRA 11.3M
- IPO Year
- ILAG 2022
- LYRA 2020
- Fundamental
- Price
- ILAG $0.57
- LYRA $5.94
- Analyst Decision
- ILAG
- LYRA Hold
- Analyst Count
- ILAG 0
- LYRA 1
- Target Price
- ILAG N/A
- LYRA $16.00
- AVG Volume (30 Days)
- ILAG 31.7K
- LYRA 51.1K
- Earning Date
- ILAG 01-01-0001
- LYRA 11-07-2025
- Dividend Yield
- ILAG N/A
- LYRA N/A
- EPS Growth
- ILAG N/A
- LYRA N/A
- EPS
- ILAG N/A
- LYRA N/A
- Revenue
- ILAG $7,506,551.00
- LYRA $770,000.00
- Revenue This Year
- ILAG N/A
- LYRA N/A
- Revenue Next Year
- ILAG N/A
- LYRA $106.28
- P/E Ratio
- ILAG N/A
- LYRA N/A
- Revenue Growth
- ILAG 16.50
- LYRA N/A
- 52 Week Low
- ILAG $0.34
- LYRA $3.81
- 52 Week High
- ILAG $1.10
- LYRA $37.50
- Technical
- Relative Strength Index (RSI)
- ILAG 44.22
- LYRA 34.62
- Support Level
- ILAG $0.55
- LYRA $6.25
- Resistance Level
- ILAG $0.65
- LYRA $7.30
- Average True Range (ATR)
- ILAG 0.04
- LYRA 0.52
- MACD
- ILAG -0.01
- LYRA -0.16
- Stochastic Oscillator
- ILAG 28.68
- LYRA 0.46
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.